FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384694911> ?p ?o ?g. }

• W4384694911 endingPage "3651" @default.
• W4384694911 startingPage "3651" @default.
• W4384694911 abstract "PD-1/PD-L1-inhibiting antibodies have shown disappointing efficacy in patients with refractory ovarian cancer (OC). Apparently, OC cells exploit nonoverlapping immunosuppressive mechanisms to evade the immune system. In this respect, the CD73-adenosine inhibitory immune checkpoint is of particular interest, as it rapidly converts pro-inflammatory ATP released from cancer cells to immunosuppressive adenosine (ADO). Moreover, cancer-cell-produced ADO is known to form a highly immunosuppressive extra-tumoral 'halo' that chronically inhibits the anticancer activity of various immune effector cells. Thus far, conventional CD73-blocking antibodies such as oleclumab show limited clinical efficacy, probably due to the fact that it indiscriminately binds to and blocks CD73 on a massive surplus of normal cells. To address this issue, we constructed a novel bispecific antibody (bsAb) CD73xEpCAM that inhibits CD73 expressed on the OC cell surface in an EpCAM-directed manner. Importantly, bsAb CD73xEpCAM showed potent capacity to inhibit the CD73 enzyme activity in an EpCAM-directed manner and restore the cytotoxic activity of ADO-suppressed anticancer T cells. Additionally, treatment with bsAb CD73xEpCAM potently inhibited the proliferative capacity of OC cells and enhanced their sensitivity to cisplatin, doxorubicin, 5FU, and ionizing radiation. BsAb CD73xEpCAM may be useful in the development of tumor-directed immunotherapeutic approaches to overcome the CD73-mediated immunosuppression in patients with refractory OC." @default.
• W4384694911 created "2023-07-20" @default.
• W4384694911 creator A5019749108 @default.
• W4384694911 creator A5039055014 @default.
• W4384694911 creator A5051758223 @default.
• W4384694911 creator A5072705437 @default.
• W4384694911 creator A5077315286 @default.
• W4384694911 creator A5091917534 @default.
• W4384694911 creator A5039422719 @default.
• W4384694911 date "2023-07-17" @default.
• W4384694911 modified "2023-10-16" @default.
• W4384694911 title "A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian Cancer" @default.
• W4384694911 cites W1516033866 @default.
• W4384694911 cites W1928191259 @default.
• W4384694911 cites W2001123680 @default.
• W4384694911 cites W2008076617 @default.
• W4384694911 cites W2022847745 @default.
• W4384694911 cites W2023977540 @default.
• W4384694911 cites W2052670628 @default.
• W4384694911 cites W2057936669 @default.
• W4384694911 cites W2059050919 @default.
• W4384694911 cites W2070830104 @default.
• W4384694911 cites W2080095423 @default.
• W4384694911 cites W2113661022 @default.
• W4384694911 cites W2117100825 @default.
• W4384694911 cites W2124054226 @default.
• W4384694911 cites W2139727788 @default.
• W4384694911 cites W2157158939 @default.
• W4384694911 cites W2266408649 @default.
• W4384694911 cites W2329974159 @default.
• W4384694911 cites W2400514548 @default.
• W4384694911 cites W2473953377 @default.
• W4384694911 cites W2474535137 @default.
• W4384694911 cites W2487379593 @default.
• W4384694911 cites W2571138221 @default.
• W4384694911 cites W2581747126 @default.
• W4384694911 cites W2588451912 @default.
• W4384694911 cites W2617696599 @default.
• W4384694911 cites W2763960561 @default.
• W4384694911 cites W2782034097 @default.
• W4384694911 cites W2784331139 @default.
• W4384694911 cites W2785041354 @default.
• W4384694911 cites W2800073762 @default.
• W4384694911 cites W2892380094 @default.
• W4384694911 cites W2901464794 @default.
• W4384694911 cites W2935412325 @default.
• W4384694911 cites W2946708904 @default.
• W4384694911 cites W2997526573 @default.
• W4384694911 cites W3033331291 @default.
• W4384694911 cites W3089626466 @default.
• W4384694911 cites W3134511527 @default.
• W4384694911 cites W3198082903 @default.
• W4384694911 cites W4210459869 @default.
• W4384694911 cites W4281932421 @default.
• W4384694911 cites W4289890606 @default.
• W4384694911 cites W4308370901 @default.
• W4384694911 doi "https://doi.org/10.3390/cancers15143651" @default.
• W4384694911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37509310" @default.
• W4384694911 hasPublicationYear "2023" @default.
• W4384694911 type Work @default.
• W4384694911 citedByCount "0" @default.
• W4384694911 crossrefType "journal-article" @default.
• W4384694911 hasAuthorship W4384694911A5019749108 @default.
• W4384694911 hasAuthorship W4384694911A5039055014 @default.
• W4384694911 hasAuthorship W4384694911A5039422719 @default.
• W4384694911 hasAuthorship W4384694911A5051758223 @default.
• W4384694911 hasAuthorship W4384694911A5072705437 @default.
• W4384694911 hasAuthorship W4384694911A5077315286 @default.
• W4384694911 hasAuthorship W4384694911A5091917534 @default.
• W4384694911 hasBestOaLocation W43846949111 @default.
• W4384694911 hasConcept C121608353 @default.
• W4384694911 hasConcept C126322002 @default.
• W4384694911 hasConcept C154317977 @default.
• W4384694911 hasConcept C159654299 @default.
• W4384694911 hasConcept C185592680 @default.
• W4384694911 hasConcept C202751555 @default.
• W4384694911 hasConcept C203014093 @default.
• W4384694911 hasConcept C2777701055 @default.
• W4384694911 hasConcept C2780427987 @default.
• W4384694911 hasConcept C2780851360 @default.
• W4384694911 hasConcept C3020495827 @default.
• W4384694911 hasConcept C502942594 @default.
• W4384694911 hasConcept C542903549 @default.
• W4384694911 hasConcept C55493867 @default.
• W4384694911 hasConcept C71924100 @default.
• W4384694911 hasConcept C8891405 @default.
• W4384694911 hasConcept C96232424 @default.
• W4384694911 hasConcept C98274493 @default.
• W4384694911 hasConceptScore W4384694911C121608353 @default.
• W4384694911 hasConceptScore W4384694911C126322002 @default.
• W4384694911 hasConceptScore W4384694911C154317977 @default.
• W4384694911 hasConceptScore W4384694911C159654299 @default.
• W4384694911 hasConceptScore W4384694911C185592680 @default.
• W4384694911 hasConceptScore W4384694911C202751555 @default.
• W4384694911 hasConceptScore W4384694911C203014093 @default.
• W4384694911 hasConceptScore W4384694911C2777701055 @default.
• W4384694911 hasConceptScore W4384694911C2780427987 @default.
• W4384694911 hasConceptScore W4384694911C2780851360 @default.

• next